[March 06, 2015] |
|
Altasciences and ITR Laboratories Form a Strategic Alliance
Altasciences, a provider of early phase clinical research services, and
ITR Laboratories, a nonclinical services organization, announced today
their strategic alliance offering clients a way to customize their drug
development programs from lead candidate selection through to early
stage clinical trials. This alliance facilitates working with a single
integrated partner in order to bring drug candidates to proof of concept
faster, and reduce costs.
"Few organizations can offer an integrated early development solution
which includes expertise in both nonclinical and clinical testing, along
with personalized service. ITR and Altasciences are customer-centric
full-service companies that provide the necessary focused expertise from
nonclinical studies to first-in-human and proof-of-concept clinical
programs, which we believe will benefit our Sponsors with customized
turn-key solutions", states Chris Perkin, Chief Executive
Officer at Altasciences.
"Both organizations hve collaborated extensively over the past 25
years and share the same approach to customer service and flexibility -
our company structure allows for quick responses and accommodates
last-minute changes easily. ITR and Altasciences have already worked
together to provide Bioanalytical services for complex analysis on
preclinical studies that will then extend to the clinical programs, this
alliance was a natural extension from which many of our clients have
already benefitted", added Ginette Bain, Senior Vice President at
ITR Laboratories Canada.
The alliance provides our clients with a single coordinated team
throughout the drug development process, minimizing delays and time lost
during the transition from nonclinical to clinical development. In
addition, the partnership will provide our clients with guidance that
leverages both ITR's and Altasciences' experience, knowledge, location
and close working relationship throughout the process.
About Altasciences
Altasciences, owned by Kilmer Capital Partners, owns Algorithme Pharma,
Algorithme Pharma USA and Vince and Associates Clinical Research. All
organizations operate with a common mission, to provide the best quality
early stage clinical development services to an international customer
base of pharmaceutical, biotechnology and generic companies with a focus
on customer service.
About ITR
ITR Canada Inc., owned by Biology and Zoology Research Center of Japan,
is an international Contract Research Organization that provides
non-clinical toxicology services for the biotechnology and
pharmaceutical industries globally. ITR offers personalized services
from planning and study program design to study implementation and
reporting for regulatory drug filing. ITR Canada is CCAC and AAALAC
accredited, and studies conducted are fully compliant with GLP.
[ Back To TMCnet.com's Homepage ]
|